Mosapride citrate dihydrate is a pharmaceutical compound primarily used as a gastroprokinetic agent, which enhances gastrointestinal motility. It is a derivative of mosapride, a selective serotonin 5-HT4 receptor agonist, and is often utilized in the treatment of functional gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and functional dyspepsia. The dihydrate form indicates that the compound contains two molecules of water, which can influence its solubility and stability. Mosapride citrate dihydrate is typically characterized by its white to off-white crystalline powder appearance and is soluble in water, making it suitable for oral formulations. Its mechanism of action involves increasing the release of acetylcholine in the gastrointestinal tract, thereby promoting peristalsis and improving digestive function. Safety and efficacy profiles are well-documented, with common side effects being mild and transient. As with any medication, it is essential to consider contraindications and interactions with other drugs when prescribing or using this compound.

Mosapride citrate dihydrate

156925-25-6: Mosapride citrate dihydrate is a pharmaceutical compound primarily used as a gastroprokinetic agent, which enhances gastrointestinal motility. It is a derivative of mosapride, a selective serotonin 5-HT4 receptor agonist, and is often utilized in the treatment of functional gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and functional dyspepsia. The dihydrate form indicates that the compound contains two molecules of water, which can influence its solubility and stability. Mosapride citrate dihydrate is typically characterized by its white to off-white crystalline powder appearance and is soluble in water, making it suitable for oral formulations. Its mechanism of action involves increasing the release of acetylcholine in the gastrointestinal tract, thereby promoting peristalsis and improving digestive function. Safety and efficacy profiles are well-documented, with common side effects being mild and transient. As with any medication, it is essential to consider contraindications and interactions with other drugs when prescribing or using this compound.

CAS 156925-25-6

Mosapride citrate dihydrate

Benzamide, 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]-, (S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI)

Ref: IN-DA001P34

Mosapride citrate

Ref: 7W-GP4865